{"denoms":[{"counts":[{"groupId":"BG000","value":"429"},{"groupId":"BG001","value":"430"},{"groupId":"BG002","value":"859"}],"units":"Participants"}],"groups":[{"description":"temozolomide 150 mg/m2/day PO, on 7 consecutive days every 14 days (\"7 days on / 7 days off\" continuously)","id":"BG000","title":"Temozolomide"},{"description":"dacarbazine 1000 mg/m2 IV, on Day 1 +/- 3 days every 3 weeks","id":"BG001","title":"Dacarbazine"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"276"},{"groupId":"BG001","value":"261"},{"groupId":"BG002","value":"537"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"153"},{"groupId":"BG001","value":"169"},{"groupId":"BG002","value":"322"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"179"},{"groupId":"BG001","value":"177"},{"groupId":"BG002","value":"356"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"250"},{"groupId":"BG001","value":"253"},{"groupId":"BG002","value":"503"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}